Literature DB >> 20807315

Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches.

Anton I Rosenbaum1, Frederick R Maxfield.   

Abstract

Cholesterol is an important lipid of mammalian cells. Its unique physicochemical properties modulate membrane behavior and it serves as the precursor for steroid hormones, oxysterols and vitamin D. Cholesterol is effluxed from the late endosomes/lysosomes via the concerted action of at least two distinct proteins: Niemann-Pick C (NPC)1 and NPC2. Mutations in these two proteins manifest as NPC disease - a very rare, usually fatal, autosomal, recessive, neurovisceral, lysosomal storage disorder. In this review, we discuss the possible mechanisms of action for NPC1 and NPC2 in mediating cholesterol efflux, as well as the different therapeutic approaches being pursued for the treatment of this lipid storage disorder.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20807315      PMCID: PMC3008286          DOI: 10.1111/j.1471-4159.2010.06976.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  64 in total

1.  Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein.

Authors:  Rodney E Infante; Lina Abi-Mosleh; Arun Radhakrishnan; Jarrod D Dale; Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2007-11-06       Impact factor: 5.157

Review 2.  Intracellular sterol transport and distribution.

Authors:  Frederick R Maxfield; Anant K Menon
Journal:  Curr Opin Cell Biol       Date:  2006-06-27       Impact factor: 8.382

3.  Sterol, protein and lipid trafficking in Chinese hamster ovary cells with Niemann-Pick type C1 defect.

Authors:  Nina H Pipalia; Mingming Hao; Sushmita Mukherjee; Frederick R Maxfield
Journal:  Traffic       Date:  2006-12-07       Impact factor: 6.215

Review 4.  Cyclodextrin-based pharmaceutics: past, present and future.

Authors:  Mark E Davis; Marcus E Brewster
Journal:  Nat Rev Drug Discov       Date:  2004-12       Impact factor: 84.694

Review 5.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

6.  Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.

Authors:  Mark E Gelsthorpe; Nikola Baumann; Elizabeth Millard; Sarah E Gale; S Joshua Langmade; Jean E Schaffer; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

7.  Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.

Authors:  Marc C Patterson; Darleen Vecchio; Helena Prady; Larry Abel; James E Wraith
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

8.  Lysobisphosphatidic acid controls endosomal cholesterol levels.

Authors:  Julien Chevallier; Zeina Chamoun; Guowei Jiang; Glenn Prestwich; Naomi Sakai; Stefan Matile; Robert G Parton; Jean Gruenberg
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

9.  Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease.

Authors:  Sujuan Xu; Brian Benoff; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

Review 10.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

View more
  104 in total

1.  The transition from a rural to an urban environment alters expression of the human Ebola virus receptor Neiman-Pick C1: implications for the current epidemic in West Africa.

Authors:  Stephen W Bickler; Radhames E Lizardo; Antonio De Maio
Journal:  Cell Stress Chaperones       Date:  2014-12-05       Impact factor: 3.667

Review 2.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

3.  Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Authors:  Niklas Mattsson; Maria Olsson; Mikael K Gustavsson; Marko Kosicek; Martina Malnar; Jan-Eric Månsson; Maria Blomqvist; Johan Gobom; Ulf Andreasson; Gunnar Brinkmalm; Charles Vite; Silva Hecimovic; Caroline Hastings; Kaj Blennow; Henrik Zetterberg; Erik Portelius
Journal:  Metab Brain Dis       Date:  2012-09-01       Impact factor: 3.584

4.  Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.

Authors:  Kanagaraj Subramanian; Navin Rauniyar; Mathieu Lavalleé-Adam; John R Yates; William E Balch
Journal:  Mol Cell Proteomics       Date:  2017-08-31       Impact factor: 5.911

Review 5.  Chemistry-enabled methods for the visualization of cell-surface glycoproteins in Metazoans.

Authors:  Kelly N Chuh; Matthew R Pratt
Journal:  Glycoconj J       Date:  2015-04-28       Impact factor: 2.916

6.  Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.

Authors:  Fabrizio Vacca; Stefania Vossio; Vincent Mercier; Dimitri Moreau; Shem Johnson; Cameron C Scott; Jonathan Paz Montoya; Marc Moniatte; Jean Gruenberg
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

7.  An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo.

Authors:  Thomas V Galassi; Prakrit V Jena; Janki Shah; Geyou Ao; Elizabeth Molitor; Yaron Bram; Angela Frankel; Jiwoon Park; Jose Jessurun; Daniel S Ory; Adriana Haimovitz-Friedman; Daniel Roxbury; Jeetain Mittal; Ming Zheng; Robert E Schwartz; Daniel A Heller
Journal:  Sci Transl Med       Date:  2018-10-03       Impact factor: 17.956

8.  Glycosylation inhibition reduces cholesterol accumulation in NPC1 protein-deficient cells.

Authors:  Jian Li; Maika S Deffieu; Peter L Lee; Piyali Saha; Suzanne R Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

9.  Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease.

Authors:  Sovan Sarkar; Bernadette Carroll; Yosef Buganim; Dorothea Maetzel; Alex H M Ng; John P Cassady; Malkiel A Cohen; Souvik Chakraborty; Haoyi Wang; Eric Spooner; Hidde Ploegh; Joerg Gsponer; Viktor I Korolchuk; Rudolf Jaenisch
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

10.  Proteomic analysis of mouse models of Niemann-Pick C disease reveals alterations in the steady-state levels of lysosomal proteins within the brain.

Authors:  David E Sleat; Jennifer A Wiseman; Istvan Sohar; Mukarram El-Banna; Haiyan Zheng; Dirk F Moore; Peter Lobel
Journal:  Proteomics       Date:  2012-11-22       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.